Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma von Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., Baurain, J.-F., D'Hondt, L., Strauven, T., Chaskis, C., In't Veld, P., Michotte, A., De Greve, J.

Volltext

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer.... von Köhne, C.-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Müller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H.-J., Bleiberg, H., Van Den Brande, J., Debois, M., Bethe, U., Van Cutsem, E.

Volltext

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study von Schrijvers, D., Van Herpen, C., Kerger, J., Joosens, E., Van Laer, C., Awada, A., Van den Weyngaert, D., Nguyen, H., Le Bouder, C., Castelijns, J. A., Kaanders, J., De Mulder, P., Vermorken, J. B.

Volltext

8744 POSTER Extended Use of Adjuvant TMZ in Newly Diagnosed GBM Patients is Safe – Results From the Safety Analysis of the PATSGO Trial von Hammouch, F, Boterberg, T, Clement, P, Joosens, E, Whenham, N, Verschaeve, V, Devriendt, D, Renard, L, Baurain, J.F.R

Volltext

Secondary non-Hodgkin lymphoma of the ethmoid sinus after temozolomide von Broes, K, Van Ginderachter, L, Joosens, E, Maes, A, Theunissen, K, Schepers, S, Deben, K, Claes, J, Mebis, J, Cox, T

Volltext

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study von Van Cutsem, E, Dirix, L, Van Laethem, J-L, Van Belle, S, Borner, M, Gonzalez Baron, M, Roth, A, Morant, R, Joosens, E, Gruia, G, Sibaud, D, Bleiberg, H

Volltext

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Mult... von von der Maase, H, Hansen, S W, Roberts, J T, Dogliotti, L, Oliver, T, Moore, M J, Bodrogi, I, Albers, P, Knuth, A, Lippert, C M, Kerbrat, P, Sanchez Rovira, P, Wersall, P, Cleall, S P, Roychowdhury, D F, Tomlin, I, Visseren-Grul, C M, Conte, P F

Volltext

000297: PHASE I STUDY OF LIPOSOMAL DOXORUBICIN COMBINED WITH GEMCITABINE IN RECURRENT OVARIAN CANCER von Vergote, L., Baurain, J.F., Joosens, E., Amant, F., Van Gramberen, M., Berteloot, P.

Volltext

Second diphtheria booster in adults raises immunity to 92 von Vellinga, Akke, Van Damme, Pierre, Joosens, Els, van der Wielen, Marie, Goossens, Herman

Volltext

Comparison of Modified Technetium-99m Albumin and Technetium-99m Red Blood Cells for Equilibrium Ventriculography von Hambye, Anne-Sophie E, Verbeke, Kristin A, Vandermeiren, Rudi P, Joosens, Eric J, Verbruggen, Alfons M, De Roo, Michel J

Volltext

New medical treatments in thyroid cancer von Clement, Paul, Decoster, L, Henry, S, Joosens, E, Cornelis, F, Specenier, P

Volltext

Temozolomide for the treatment of recurrent supratentorial glioma: results of a compassionate use program in Belgium von EVERAERT, Els, NEYNS, Bart, JOOSENS, Eric, STRAUVEN, Theo, BRANLE, Fabrice, MENTEN, Johan

Volltext

A multicenter stratified phase II study of cetuximab for the treatment of patients with recurrent high-grade glioma von Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., Baurain, J. F., D'Hondt, L., Chaskis, C., Michotte, A., De Greve, J.

Volltext

A phase II study of temozolomide administered 21 out of 28 days for the treatment of patients with recurrent anaplastic (oligo) astrocytoma: An interim analysis of toxicity von Neyns, B., van Mierlo, B., Menten, J., Dhondt, L., Joosens, E., Vastesaeger, N., Branle, F.

Volltext

Temozolomide for the treatment of recurrent glioma: Results of a compassionate use program in Belgium von Neyns, B., Everaert, E., Joosens, E., Strauven, T., Branle, F., Menten, J.

Volltext

Temozolomide for the treatment of recurrent glioma: Results of a compassionate use program in Belgium von Neyns, B., Everaert, E., Joosens, E., Strauven, T., Branle, F., Menten, J.

Volltext

A stratified phase II study of cetuximab for the treatment of recurrent glioblastoma multiforme: Preliminary results von Sadones, J., Chaskis, C., Joosens, E. J., Dhondt, L. A., Baurain, J., In ’t Veld, P., Michotte, A., De Grève, J., Neyns, B.

Volltext

Changes in Arterial Oxygen Tension after Gastric Lavage for Drug Overdose von Jorens, Philippe G., Joosens, Eric J., Nagler, Jan M.

Volltext

The place of death of cancer patients in Antwerp von Schrijvers, D, Joosens, E, Vandebroek, J, Verhoeven, A

Volltext

Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m2 in locally advanced (LA) or metastatic breast cancer (MBC) von Wilke, H., Joosens, E., Hess, D., Gozdz, S., Cabral, S., Orlandi, L., Reksodiputro, H., Khoo, K.S., Boussard, B., Köhne, H.

Volltext